Peking Union-Lawke Biomedical Development Limited
PPD launches Global Central Lab Services in China
PPD has expanded its global central lab services into China through an agreement with Peking Union Lawke Biomedical Development Limited (PUL).
The agreement allows PPD to immediately begin providing biopharmaceutical clients with its full range of highly customized central lab services in China.
"Chinese law makes it extremely difficult to export lab samples to other countries for testing," said Agostino L. Fede, senior vice president of PPD and head of PPD's global central labs. "Our agreement with PUL expands our global central lab capabilities in a high growth clinical research market. It also saves our clients time and money by providing lab results more quickly without incurring expenses for exporting shipments."
PPD invested in laboratory equipment located at Peking Union Medical College. The equipment is identical to platforms located at PPD's global central labs in Brussels, Belgium, and Highland Heights, Ky., and assays performed have been extensively cross validated and precisely calibrated to match instruments at these labs. With these and other ongoing quality assurance measures, PUL and PPD deliver laboratory data that are directly combinable. In addition, PUL is interfaced real-time to ConneXion, PPD's proprietary computer system, to assure consistent management and reporting.
Jian Ho, medical director at PUL, will oversee the lab while PPD will lead project management and investigator services and work with clients on study set-up. As part of the agreement, PUL will conduct chemistry, haematology, urinalysis and haemoglobin A1c tests to support PPD's clinical trials business in China. PUL also offers an extensive range of esoteric tests. In return, PUL will have rights to use the equipment to conduct central lab testing for Chinese clients running clinical trials in China.... more